Versant Venture Management, LLC — 13F Holdings

2026 Q3  ·  8 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Versant Venture Management, LLC maintained a portfolio of 8 distinct positions. They heavily accumulated shares in Contineum Therapeutics, Inc., increasing the position by 138.2%. The fund also reduced its exposure to Skye Bioscience, Inc. by 87.5%.
Position History hover any row below to update
Loading…
Versant Venture Management, LLC San Francisco, CA Venture Capital / Asset Manager AUM $109M
PCA Score Concentration Risk
Risk ENB
Total Positions
8
Quarter
2026 Q3
Top Holding
GLUE (34.8%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-8 of 8

Versant Venture Management, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
GLUE
Monte Rosa Ther...
Healthcare 34.78% 47.34% #1
Prev: #1
7.0
—
no change no change
P
S
3,180,780 $37,946,705 2024 Q4 13F Filing 2026-09-30 2026-11-13
IPSC
Century Therape...
Healthcare 19.07% 18.33% #2
Prev: #2
6.5
—
no change no change
P
S
12,166,109 $20,804,046 2026 Q1 13F Filing 2026-09-30 2026-11-13
CTNM
Contineum Thera...
Healthcare 15.90% 5.47% #3 2
Prev: #5
8.0
—
750,000 138.2%
P
S
1,292,628 $17,347,068 2024 Q2 13F Filing 2026-09-30 2026-11-13
JBIO
Jade Bioscience...
Healthcare 12.77% 13.55% #4 1
Prev: #3
5.5
—
no change no change
P
S
991,783 $13,934,551 2025 Q2 13F Filing 2026-09-30 2026-11-13
LENZ
Lenz Therapeuti...
Healthcare 9.35% 9.28% #5 1
Prev: #4
5.2
—
no change no change
P
S
2,656,888 $10,202,450 2025 Q3 13F Filing 2026-09-30 2026-11-13
CRSP
CRISPR Therapeu...
Healthcare 7.55% 4.99% #6
Prev: #6
4.0
—
no change no change
P
S
148,831 $8,233,331 2018 Q1 13F Filing 2026-09-30 2026-11-13
SKYE
Skye Bioscience...
Healthcare 0.37% 0.86% #7
Prev: #7
0.1
—
-1,756,742 -87.5%
P
S
250,962 $404,049 2024 Q1 13F Filing 2026-09-30 2026-11-13
N/A
Tempest Therape...
Unknown 0.21% 0.18% #8
Prev: #8
1.1
—
no change no change
P
S
269,772 $225,071 — 13F Filing 2026-09-30 2026-11-13
Showing 1-8 of 8 holdings

Unlock Full Versant Venture Management, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →